"Salicylates" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The salts or esters of salicylic acids, or salicylate esters of an organic acid. Some of these have analgesic, antipyretic, and anti-inflammatory activities by inhibiting prostaglandin synthesis.
| Descriptor ID |
D012459
|
| MeSH Number(s) |
D02.241.223.100.300.595 D02.241.511.390.595 D02.455.426.559.389.127.281.595 D02.455.426.559.389.657.410.595
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Salicylates".
Below are MeSH descriptors whose meaning is more specific than "Salicylates".
This graph shows the total number of publications written about "Salicylates" by people in this website by year, and whether "Salicylates" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 1 | 0 | 1 |
| 1995 | 1 | 0 | 1 |
| 1997 | 1 | 1 | 2 |
| 1999 | 0 | 2 | 2 |
| 2000 | 0 | 2 | 2 |
| 2001 | 1 | 0 | 1 |
| 2004 | 0 | 1 | 1 |
| 2005 | 3 | 0 | 3 |
| 2006 | 0 | 1 | 1 |
| 2007 | 0 | 1 | 1 |
| 2008 | 0 | 1 | 1 |
| 2009 | 2 | 0 | 2 |
| 2010 | 2 | 1 | 3 |
| 2012 | 1 | 1 | 2 |
| 2013 | 2 | 0 | 2 |
| 2015 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Salicylates" by people in Profiles.
-
Articles You May Have Missed. J Med Toxicol. 2018 Mar; 14(1):104-107.
-
Phase I study of S-trans, trans-farnesylthiosalicylic acid (salirasib), a novel oral RAS inhibitor in patients with refractory hematologic malignancies. Clin Lymphoma Myeloma Leuk. 2015 Jul; 15(7):433-438.e2.
-
Comparison of antimicrobial activity of zinc chloride and bismuth subsalicylate against clinical isolates of Helicobacter pylori. Microb Drug Resist. 2014 Aug; 20(4):305-9.
-
Design, evaluation, and dissemination of a plastic syringe clip to improve dosing accuracy of liquid medications. Ann Biomed Eng. 2013 Sep; 41(9):1860-8.
-
Ginkgolic acid inhibits HIV protease activity and HIV infection in vitro. Med Sci Monit. 2012 Aug; 18(8):BR293-298.
-
Integrated preclinical and clinical development of S-trans, trans-Farnesylthiosalicylic Acid (FTS, Salirasib) in pancreatic cancer. Invest New Drugs. 2012 Dec; 30(6):2391-9.
-
Defective CFTR induces aggresome formation and lung inflammation in cystic fibrosis through ROS-mediated autophagy inhibition. Nat Cell Biol. 2010 Sep; 12(9):863-75.
-
Salirasib in the treatment of pancreatic cancer. Future Oncol. 2010 Jun; 6(6):885-91.
-
Phase 1 first-in-human clinical study of S-trans,trans-farnesylthiosalicylic acid (salirasib) in patients with solid tumors. Cancer Chemother Pharmacol. 2010 Jan; 65(2):235-41.
-
The role of modified Jessner's solution with 35% trichloroacetic acid peel. Plast Reconstr Surg. 2009 Sep; 124(3):965-966.